Phosphate ion
- Generic Name
- Phosphate ion
- Drug Type
- Small Molecule
- Chemical Formula
- O4P
- CAS Number
- 14265-44-2
- Unique Ingredient Identifier
- NK08V8K8HR
Remineralization Effect of Fluoride Varnishes on Permanent Molars
- Conditions
- Remineralization
- Interventions
- First Posted Date
- 2019-10-14
- Last Posted Date
- 2019-10-15
- Lead Sponsor
- Kırıkkale University
- Target Recruit Count
- 40
- Registration Number
- NCT04124887
- Locations
- 🇹🇷
Kırıkkale University, Kırıkkale, Turkey
Mandibular Furcation III Regeneration (FURC-III-REGEN)
- Conditions
- Furcation DefectsPeriodontal Diseases
- Interventions
- Device: Biphasic calcium phosphate (Straumann Bone Ceramic) + collagen membrane (Straumann Jason Membrane)
- First Posted Date
- 2019-08-16
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- University of Oslo
- Target Recruit Count
- 5
- Registration Number
- NCT04059458
- Locations
- 🇳🇴
Institute of Clinical Dentistry, Faculty of Dentistry, University of Oslo, Oslo, Norway
Mandibular Furcation II Regeneration
- Conditions
- Furcation DefectsPeriodontal Diseases
- Interventions
- Device: Biphasic calcium phosphate (Straumann Bone Ceramic) + collagen membrane (Straumann Jason Membrane)
- First Posted Date
- 2019-08-16
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- University of Oslo
- Target Recruit Count
- 5
- Registration Number
- NCT04059445
- Locations
- 🇳🇴
Institute of Clinical Dentistry, Faculty of Dentistry, University of Oslo, Oslo, Norway
The Causal Connection Between Sng and Muscle Acidosis
- First Posted Date
- 2019-08-08
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Taipei Medical University Hospital
- Target Recruit Count
- 52
- Registration Number
- NCT04049253
- Locations
- 🇨🇳
Taipei Medical University Hospital, Taipei City, No.252, Wusing St., Sinyi Dist., Taiwan
DP13 - A Phase II Study in Patients With Primary Aldosteronism
- First Posted Date
- 2019-07-05
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Damian Pharma AG
- Target Recruit Count
- 35
- Registration Number
- NCT04007406
- Locations
- 🇮🇹
Ospedale Molinette, Torino, Italy
Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like Symptoms
- Conditions
- Severe Influenza
- Interventions
- First Posted Date
- 2019-05-13
- Last Posted Date
- 2019-05-15
- Lead Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT03947411
- Locations
- 🇨🇳
The First Affliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China
Ectoin® Mouth Wash (EML03) in the Prevention and Treatment of Radiation-induced Oral Mucositis
- Conditions
- Oral Mucositis Due to Radiation
- Interventions
- Drug: Ectoin Mouth Wash
- First Posted Date
- 2019-04-30
- Last Posted Date
- 2019-11-06
- Lead Sponsor
- Bitop AG
- Target Recruit Count
- 52
- Registration Number
- NCT03932292
- Locations
- 🇭🇺
Department of Radiotherapy, National Institute of Oncology, Budapest, Hungary
Stress and Fetal Brain Development
- First Posted Date
- 2019-02-05
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 24
- Registration Number
- NCT03831126
- Locations
- 🇩🇪
University Hospital Tuebingen, Department of Women's Health, Tuebingen, Germany
Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy
- Conditions
- Hyperphosphatemia
- Interventions
- First Posted Date
- 2019-01-31
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Ardelyx
- Target Recruit Count
- 236
- Registration Number
- NCT03824587
- Locations
- 🇺🇸
Nephrology Consultants, LLC, Huntsville, Alabama, United States
🇺🇸Mountain Kidney & Hypertension Associates, P.A., Asheville, North Carolina, United States
🇺🇸California Institute of Renal Research - Chula Vista, Chula Vista, California, United States
Randomized Controlled Trail of Polyethylene Glycol vs Sodium Phosphate for Colonic Cleansing of Colonoscopy
- Conditions
- Polyethylene GlycolSodium Phosphate
- Interventions
- First Posted Date
- 2019-01-25
- Last Posted Date
- 2020-04-17
- Lead Sponsor
- Dong Yang
- Target Recruit Count
- 586
- Registration Number
- NCT03817788
- Locations
- 🇨🇳
the First Hospital of Jilin University, Chang chun, Jilin, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.